RVL Pharmaceuticals plc Income Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations and Comprehensive Loss

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Revenues
Net product sales
Royalty Revenue
Licensing and Contract Revenue
Royalty and licensing revenue
Total revenues
Cost of goods sold
Gross profit
Selling, general and administrative expenses
Research and development expenses
Impairment of intangibles and fixed assets
Impairment of intangibles
Impairment of goodwill
Impairment of intangible assets
Total operating expenses
Operating loss before gain on sales of product rights, net
Gain on sales of product rights, net
Operating loss
Interest expense and amortization of debt discount
Other non-operating (income) loss, net
Change in fair value of debt and interest expense
Change in fair value of warrants
Other non-operating (income) expense, net
Total other non-operating expense
Total other non-operating income
Loss before income taxes
Income tax (benefit) expense, continuing operations
Loss from continuing operations
Gain on sales of discontinued operations
Income from discontinued operations before income taxes
Income tax benefit, discontinued operations
Income from discontinued operations, net of tax
Net loss
Reclassification adjustment of cumulative foreign currency translation losses, net of tax
Change in fair value of debt due to change in credit risk, net of tax
Other comprehensive (loss) income
Comprehensive loss
(Loss) earnings per ordinary share:
Basic
Diluted
Loss per share attributable to shareholders, basic and diluted
(Loss) earnings per ordinary share, Continuing operations, basic
(Loss) earnings per ordinary share, Continuing operations, diluted
(Loss) earnings per ordinary share, Discontinued operations, basic
(Loss) earnings per ordinary share, Discontinued operations, diluted
(Loss) earnings per ordinary share, basic
(Loss) earnings per ordinary share, diluted

Weighted average ordinary shares outstanding:
Basic and Diluted
Weighted average shares, basic and diluted
Weighted average ordinary shares outstanding, basic
Weighted average ordinary shares outstanding, diluted

Comments